Chelation improves heart outcomes in diabetes patients

11/21/2013 | Medscape (free registration)

Chelation therapy was associated with lower rates of death, recurrent myocardial infarction and coronary revascularization in diabetes patients compared with placebo treatment, research presented at the American Heart Association meeting and published in Circulation: Cardiovascular and Quality Outcomes indicated. However, patients in the nondiabetes arm did not appear to benefit from the treatment, researchers said.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN